16^th International Virology Summit

In spite of the success of currently available vaccines, there is a clear requirement for the development of vaccines against a number of infectious diseases for which vaccines are not yet available, or are insufficient, including HIV, hepatitis C virus, RSV, Neisseria meningitides serotype B, Group A and B, streptococcus, tuberculosis, and malaria.  Unfortunately, these pathogens have proven difficult to control with traditional vaccines, and novel approaches will be required. New efficient vaccines may also be required to protect against a number of emerging or re-emerging infectious diseases, including severe acute respiratory syndrome, corona, Ebola, Hanta and Dengue viruses.

Coronavirus (COVID-19) outbreak in China

Timing of antiviral therapy for seasonal influenza

Modified vaccinia Ankara vaccine for prevention of smallpox